Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 234108-73-7 | MDL No. : | MFCD07781158 |
Formula : | C10H13ClN2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | SJCKHLJWAXGPGT-UHFFFAOYSA-N |
M.W : | 228.68 | Pubchem ID : | 21858447 |
Synonyms : |
|
Num. heavy atoms : | 15 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.4 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 59.49 |
TPSA : | 51.22 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.42 cm/s |
Log Po/w (iLOGP) : | 2.41 |
Log Po/w (XLOGP3) : | 3.2 |
Log Po/w (WLOGP) : | 2.89 |
Log Po/w (MLOGP) : | 1.4 |
Log Po/w (SILICOS-IT) : | 1.78 |
Consensus Log Po/w : | 2.34 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.31 |
Solubility : | 0.113 mg/ml ; 0.000495 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.95 |
Solubility : | 0.0258 mg/ml ; 0.000113 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.6 |
Solubility : | 0.0574 mg/ml ; 0.000251 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.12 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | With triethylamine In dichloromethane at 20℃; | Example 8; 2-[4-(2-Carboxyethy1)phenyl]-4-(3-heptyl-1- methylureido)pyridini\\3m acetate; a. tert-Butyl (2-chlox:opyrlcL-4-yl)carbamate; 1.69 g (7.78 mmol, 1 eq) of tert-butyl dicarbonate dissolved in 50 ml of dichloromethane, in the presence of 95 mg of dimethylaminopyridine, are added to a solution of 1 g (7.78 mmol, 1 eq) of 4-amino-2-chloropyridine in 30 mL of dichloromethane in EPO <DP n="51"/>the presence of 1.19 mL (1.19 mmol, 1.1 eq) of triethylamine. The reaction mixture is stirred overnight at room temperature. The reaction is stopped by adding 100 ml of water and is then extracted with dichloromethane. The organic phases are combined and dried over sodium sulfate. The solvents are evaporated off and the residue is then chromatographed on silica gel (70/30 to 50/50 heptane/ethyl acetate) . The oil obtained is crystallized from pentane. 1.40 g of tert- butyl (2-chloropyrid~4-yl) carbamate are obtained. Yield = 80percent. |
77% | Stage #1: With sodium hexamethyldisilazane In tetrahydrofuran at 20℃; for 0.5 h; |
StepA; ci 1) NaHMDS N T) HGF0C20 l l l 9\\NH2 NHBoc the c : 2 [0073] To A solution containing 4-amino-2-chloropyridine (3. 05 g, 23. 72 mmol) in THF (24 ML) was added sodium bis (TRIMETHYLYSILYL) amide (47. 45 mmol) and stirred at room temperature for 30 minutes. To this solution was added BOC20 (23. 72 mmol) and the gelatinous mixture was stirred overnight. The reaction was diluted with water and extracted with ETOAC. The combined organic phase was washed with water and brine and dried over NA2S04 and concentrated to yield 4. 17 G (77percent). M+H+ (230). |
73% | at 20℃; for 18 h; | A mixture of 4-amino-2-chloropyridine (193 mg, 1.50 mmol), di-tert-butyl-di- carbonate (393 mg, 1.80 mmol) and 4-dimethylaminopyridine (1.8 mg, 0.02 mmol) in acetonitrile (5 mL) was stirred at room temperature for 18 hours. This mixture was concentrated under reduced pressure. The residue was purified by column chroma- tography on silica-gel (hexane/ethyl acetate, 20: 1) to give tert-butyl (2-chloropyridin- 4-YL) carbamate (250 mg, 73percent). |
[ 370864-66-7 ]
tert-Butyl (2-chloro-3-methylpyridin-4-yl)carbamate
Similarity: 0.91
[ 501907-61-5 ]
tert-Butyl (2,6-dichloropyridin-4-yl)carbamate
Similarity: 0.88
[ 494767-22-5 ]
tert-Butyl 4-chloro-2,3-dihydro-1H-pyrrolo[3,2-c]pyridine-1-carboxylate
Similarity: 0.79
[ 1151665-15-4 ]
tert-Butyl 2-chloro-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate
Similarity: 0.75
[ 171178-45-3 ]
tert-Butyl (6-chloropyridin-3-yl)carbamate
Similarity: 0.73
[ 370864-66-7 ]
tert-Butyl (2-chloro-3-methylpyridin-4-yl)carbamate
Similarity: 0.91
[ 501907-61-5 ]
tert-Butyl (2,6-dichloropyridin-4-yl)carbamate
Similarity: 0.88
[ 494767-22-5 ]
tert-Butyl 4-chloro-2,3-dihydro-1H-pyrrolo[3,2-c]pyridine-1-carboxylate
Similarity: 0.79
[ 56700-70-0 ]
tert-Butyl pyridin-3-ylcarbamate
Similarity: 0.77
[ 370864-66-7 ]
tert-Butyl (2-chloro-3-methylpyridin-4-yl)carbamate
Similarity: 0.91
[ 501907-61-5 ]
tert-Butyl (2,6-dichloropyridin-4-yl)carbamate
Similarity: 0.88
[ 56700-70-0 ]
tert-Butyl pyridin-3-ylcarbamate
Similarity: 0.77
[ 116026-93-8 ]
tert-Butyl (3-formylpyridin-4-yl)carbamate
Similarity: 0.77
[ 370864-66-7 ]
tert-Butyl (2-chloro-3-methylpyridin-4-yl)carbamate
Similarity: 0.91
[ 501907-61-5 ]
tert-Butyl (2,6-dichloropyridin-4-yl)carbamate
Similarity: 0.88
[ 56700-70-0 ]
tert-Butyl pyridin-3-ylcarbamate
Similarity: 0.77
[ 116026-93-8 ]
tert-Butyl (3-formylpyridin-4-yl)carbamate
Similarity: 0.77